SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-294847
Filing Date
2020-11-16
Accepted
2020-11-16 16:35:33
Documents
15
Period of Report
2020-11-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d82880d8k.htm   iXBRL 8-K 28566
2 EX-99.1 d82880dex991.htm EX-99.1 10317
7 GRAPHIC g82880g1116090031684.jpg GRAPHIC 2229
  Complete submission text file 0001193125-20-294847.txt   207163

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pfe-20201116.xsd EX-101.SCH 4526
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pfe-20201116_def.xml EX-101.DEF 13710
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pfe-20201116_lab.xml EX-101.LAB 22719
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pfe-20201116_pre.xml EX-101.PRE 14678
8 EXTRACTED XBRL INSTANCE DOCUMENT d82880d8k_htm.xml XML 6259
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 201317640
SIC: 2834 Pharmaceutical Preparations